Accelerate to discover

Back to filter

Related topics

Hypoxia in the Tumor Immune Microenvironment (TIME)

Bruker Biospin

Jun 6, 2024

Thursday, 11 July 2024, 16:00 CET | 10:00 EST
Zaver M. Bhujwalla, PhD...

Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics

Spectral Instruments Imaging

Jun 3, 2024

Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM
...

Have you missed any recent Cytek webinars? Watch webinars and product tutorial videos at any time

Cytek Biosciences

Apr 23, 2024

Have you missed any recent Cytek webinars? Watch webinars and product tutorial videos at any time at Cytek website....

Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic

Bruker Biospin

Apr 2, 2024

25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical
...

Jun 24, 2024

Multiplexed tissue imaging using the Orion platform to reveal the Spatial Biology of Cancer

RareCyte

Mar 27, 2024

In this webinar Prof. Sandro Santagata, will reveal how Orion high-plex imaging and the use of this data, is valuable...

Improve your data resolution with Cytek Autofluorescence Extraction tool!

Cytek Biosciences

Feb 5, 2024

Samples with high autofluorescence (AF) can be difficult to resolve with conventional flow cytometry, especially if...

Webinar: transforming Calcium Flux analysis with Cytek Full Spectrum Profiling Technology

Cytek Biosciences

Jan 4, 2024

The research described in this webinar harnesses the innovative capabilities of FSP technology to perform advanced...

Jun 24, 2024

Webinar recording: BioFlux, the gold standard for Platelet Biology and Vascular Pharmacology studies

Cell Microsystems

Jan 3, 2024

The BioFlux system give you the ability to introduce physiological shear flow to your research and drug discovery...

Show all topics (10)

Next generation karyotyping: detecting cancer-associated structural variants using optical maps

Apr 19, 2017

James Broach, PhD, Penn State Hershey, Pennsylvania, United States.

Identification of structural variants (SVs) is critical to the prognosis of acute myeloid leukemia (AML) and other hematologic malignancies. SVs are not readily identified by next generation sequencing methods and are currently diagnosed by cytogenetics, an intrinsically low resolution tool. Dr. James Broach from Penn State Hershey will discuss a new method for determining large SVs as a clinical tool for evaluating AML and other cancer genomes using Bionano optical mapping. Dr. Broach has applied this technology for detection of SVs in a variety of cancer cell lines and directly from leukemia patient blood samples.  In all cases, they have identified all the SVs reported by classic cytogenetic analysis and, in addition, a large number of translocations, deletions and insertions not observed by cytogenetics.

Register now

Webinar

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

BioNano Genomics

A revolutionary NanoChannel technology for Genome mapping of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias.

Related products

Genome maps of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias

show detail

Saphyr provides rapid, high-throughput, long-range genome mapping with unmatched structural variation discovery capabilities

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey